EFSA says CBD safety data “cannot currently be established”

By Shane Starling

- Last updated on GMT

 © Getty Images
© Getty Images

Related tags: Cbd, Efsa, Novel food

The European Food Safety Authority (EFSA) has issued a wide-ranging opinion calling for more safety data for CBD products that could challenge the Novel Foods status of many offerings in the nascent category across the bloc and beyond.

“The effect of CBD on liver, gastrointestinal tract, endocrine system, nervous system and on psychological function needs to be clarified,”wrote​ EFSA’s Panel on Nutrition, Novel Foods and Food Allergens (NDA).

The Panel added: “Studies in animals show significant reproductive toxicity, and the extent to which this occurs in humans generally and in women of child-bearing age specifically needs to be assessed. Considering the significant uncertainties and data gaps, the Panel concludes that the safety of CBD as a NF cannot currently be established.”

Look to NutraIngredients for reactions to this opinion in the coming days.

Related news

Show more

Related products

show more

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

Total Solutions for Cognitive Health by Lubrizol

Total Solutions for Cognitive Health by Lubrizol

Lipofoods, a Lubrizol Company | 05-May-2022 | Technical / White Paper

Globally, health and wellbeing have shifted from a focus on physical health and nutrition to also include cognitive and mental wellness, therefore consumers...

Mediterranean Nutraceutical products

Mediterranean Nutraceutical products

Esserre Pharma | 19-Apr-2022 | Product Brochure

From the best Mediterranean ingredients to effective and safe finished products, Esserre Pharma researches and develops unique formulations.

Related suppliers

Follow us

Products

View more

Webinars